Abstract
Transgenic mice carrying either a 1.008 or a 4.225 kb of the mouse c-kit 5′-flanking sequences linked to the oncogenic large T antigen (TAg) region of the simian virus 40 (SV40) genome were generated to test if the c-kit promoter could be used to develop useful mouse models. Both constructs promote tumourigenesis in the pituitary and the thyroid with high efficiency. The cell types from which each of these tumours derives were identified. Tumours of the pituitary derive from α-MSH-expressing cells located in the intermediate lobe. Transformed cells of the thyroid were calcitonin-positive, implying that the tumours derive from C cells or their precursors. Chromogranin A and neuron-specific enolase, general neuroendocrine cell markers, were expressed in both tumour types. Furthermore a variety of tumours appeared in the transgenic mice. Several of them stained positively for chromogranin A and/or neuron-specific enolase. This suggests a previously unsuspected tissue-specificity of the c-kit 5′ flanking sequences for neuroendocrine cells. The Kit-TAg transgenic mouse lines may represent a valuable model for the study of the development and the biology of neuroendocrine tumours.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bossé, P., Bernex, F., De Sepulveda, P. et al. Multiple neuroendocrine tumours in transgenic mice induced by c-kit-SV40 T antigen fusion genes. Oncogene 14, 2661–2670 (1997). https://doi.org/10.1038/sj.onc.1201122
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1201122
Keywords
This article is cited by
-
Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin)
BMC Psychiatry (2013)
-
KIT protein expression and mutational status of KIT gene in pituitary adenomas
Virchows Archiv (2012)
-
The Genomic Revolution and Endocrine Pathology
Endocrine Pathology (2008)
-
Characterization of C-Kit (CD117) Expression in Human Normal Pituitary Cells and Pituitary Adenomas
Endocrine Pathology (2008)